Technology Connecting Patients to Clinical Trials

TrialTech Medical, part of the Scarritt Group Companies portfolio, uses state of the art technology to expand trial awareness, including outreach to underrepresented patient populations.

On Average 80-85% of referred patients sign and ICF

Facilitation of medical records

Site support services

Minimal start up costs with no long term contract

Results based fees

Reduced coordinator workload

Continued engagement with referred patients until an ICF is signed

Real time metrics and analytics

Expanded outreach to patients with unmet medical needs

Seamless communication between study teams and TrialTech Medical